Geneseeq Technology Inc. is a precision oncology company specializing in genomic testing and research services. With a focus on next-generation sequencing (NGS), Geneseeq offers a diverse range of products including pan-cancer genetic tests and liquid biopsy solutions. The company differentiates itself through its advanced technology, extensive partnerships, and a commitment to quality and efficiency in cancer care. Geneseeq has established a strong market position with over 1,000,000 samples sequenced, 800+ hospitals utilizing its products, and a robust pipeline of clinical projects and publications, making it a key player in the precision medicine landscape.
Something looks off?